ACA

Avoro Capital Advisors Portfolio holdings

AUM $10.2B
1-Year Est. Return 119.73%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+119.73%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$2.44B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$272M
2
+$256M
3
+$241M
4
RVMD icon
Revolution Medicines
RVMD
+$142M
5
TERN icon
Terns Pharmaceuticals
TERN
+$101M

Top Sells

1
+$334M
2
+$188M
3
+$141M
4
TRML
Tourmaline Bio
TRML
+$122M
5
FOLD icon
Amicus Therapeutics
FOLD
+$118M

Sector Composition

1 Healthcare 96.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$21.7B
$1.27B 12.48%
2,606,060
+583,838
ASND icon
2
Ascendis Pharma
ASND
$14.3B
$1.09B 10.71%
5,111,111
+1,111
MDGL icon
3
Madrigal Pharmaceuticals
MDGL
$9.81B
$1.05B 10.35%
1,807,500
-25,500
ARGX icon
4
argenx
ARGX
$47.5B
$833M 8.18%
990,000
KRYS icon
5
Krystal Biotech
KRYS
$8.06B
$712M 7%
2,888,888
+111,111
ARWR icon
6
Arrowhead Research
ARWR
$8.86B
$705M 6.93%
10,625,000
-275,000
KYMR icon
7
Kymera Therapeutics
KYMR
$7.31B
$582M 5.72%
7,474,747
+1,124,747
GPCR icon
8
Structure Therapeutics
GPCR
$4.45B
$456M 4.48%
6,555,555
+1,400,000
RNAM
9
Avidity Biosciences
RNAM
$11.2B
$393M 3.87%
5,455,000
-2,190,000
CNTA
10
Centessa Pharmaceuticals
CNTA
$3.97B
$364M 3.58%
14,555,555
+3,747,475
CELC icon
11
Celcuity
CELC
$5.17B
$310M 3.05%
+3,111,111
APLS icon
12
Apellis Pharmaceuticals
APLS
$2.68B
$307M 3.02%
12,222,222
VERA icon
13
Vera Therapeutics
VERA
$2.9B
$298M 2.93%
5,888,888
-321,112
XBI icon
14
State Street SPDR S&P Biotech ETF
XBI
$8.13B
$256M 2.52%
+2,100,000
XENE icon
15
Xenon Pharmaceuticals
XENE
$3.34B
$243M 2.39%
5,424,444
+24,444
TERN icon
16
Terns Pharmaceuticals
TERN
$4.58B
$176M 1.73%
+4,350,000
RVMD icon
17
Revolution Medicines
RVMD
$19.7B
$173M 1.7%
+2,170,000
QURE icon
18
uniQure
QURE
$974M
$147M 1.45%
6,150,000
+1,705,556
SLNO icon
19
Soleno Therapeutics
SLNO
$2.1B
$134M 1.32%
2,900,000
+322,223
OCUL icon
20
Ocular Therapeutix
OCUL
$1.95B
$131M 1.29%
10,777,777
+527,777
TSHA icon
21
Taysha Gene Therapies
TSHA
$1.24B
$119M 1.17%
21,700,000
DFTX
22
Definium Therapeutics
DFTX
$1.72B
$67M 0.66%
+5,000,000
VRDN icon
23
Viridian Therapeutics
VRDN
$2.8B
$46.7M 0.46%
+1,500,000
ORKA
24
Oruka Therapeutics
ORKA
$1.67B
$40.4M 0.4%
1,333,340
ALKS icon
25
Alkermes
ALKS
$4.97B
$39.2M 0.39%
1,400,000
-840,000
1
2